Evidence map›Paper›PMID 37768550›Full record

SynthesisJournal of nephrology2024

Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions.

Giorgio Cazzaniga, Mattia Rossi, Albino Eccher, Ilaria Girolami, Vincenzo L'Imperio, Hien Van Nguyen, Jan Ulrich Becker, María Gloria Bueno García, Marta Sbaraglia, Angelo Paolo Dei Tos and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Giorgio Cazzaniga *Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy. giorgio9cazzaniga@gmail.com.ORCID 0000-0001-5373-0611
Mattia Rossi *Division of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy.
Albino EccherDepartment of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le Stefani n. 1, 37126, Verona, Italy.
Ilaria GirolamiDepartment of Pathology and Diagnostics, University and Hospital Trust of Verona, P.le Stefani n. 1, 37126, Verona, Italy.
Vincenzo L'ImperioDepartment of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy.ORCID 0000-0002-9284-2998
Hien Van NguyenDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX, 77004, USA.
Jan Ulrich BeckerInstitute of Pathology, University Hospital of Cologne, Cologne, Germany.
María Gloria Bueno GarcíaVISILAB Research Group, E.T.S. Ingenieros Industriales, University of Castilla-La Mancha, Ciudad Real, Spain.
Marta SbaragliaDepartment of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.
Angelo Paolo Dei TosDepartment of Pathology, Azienda Ospedale-Università Padova, Padua, Italy.
Giovanni GambaroDivision of Nephrology, Department of Medicine, University of Verona, Piazzale Aristide Stefani, 1, 37126, Verona, Italy.
Fabio PagniDepartment of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy.ORCID 0000-0001-9625-1637

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionArtificial intelligence (AI) integration in nephropathology has been growing rapidly in recent years, facing several challenges including the wide range of histological techniques used, the low occurrence of certain diseases, and the need for data sharing. This narrative review retraces the history of AI in nephropathology and provides insights into potential future developments.

methodsElectronic searches in PubMed-MEDLINE and Embase were made to extract pertinent articles from the literature. Works about automated image analysis or the application of an AI algorithm on non-neoplastic kidney histological samples were included and analyzed to extract information such as publication year, AI task, and learning type. Prepublication servers and reviews were not included.

resultsSeventy-six (76) original research articles were selected. Most of the studies were conducted in the United States in the last 7 years. To date, research has been mainly conducted on relatively easy tasks, like single-stain glomerular segmentation. However, there is a trend towards developing more complex tasks such as glomerular multi-stain classification.

conclusionDeep learning has been used to identify patterns in complex histopathology data and looks promising for the comprehensive assessment of renal biopsy, through the use of multiple stains and virtual staining techniques. Hybrid and collaborative learning approaches have also been explored to utilize large amounts of unlabeled data. A diverse team of experts, including nephropathologists, computer scientists, and clinicians, is crucial for the development of AI systems for nephropathology. Collaborative efforts among multidisciplinary experts result in clinically relevant and effective AI tools.

Indexed as

AlgorithmsArtificial IntelligenceKidneyColoring AgentsHumansColoring AgentsArtificial intelligenceClassificationImage analysisMachine learningNephropathologySegmentation

Identifiers

PMID37768550
PMCPMC10920416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.